Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke W Meredith

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Virology|May 22, 2015
Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based RecombinantChristian K Mathiesen, Jannick Prentoe, Luke W Meredith, et al.
Ebiomedicine|January 19, 2020
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patientsJanet T Scott, Raman Sharma, Luke W Meredith, et al.
Influenza and Other Respiratory Viruses|November 15, 2023
Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID-19 and preparedness for other emerging infectious diseases in the Islamic Emirate of AfghanistanMurad Momin Khan, Mohamed Mostafa Tahoun, Luke W Meredith, et al.
Journal of Virology|December 5, 2014
Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodiesAnnalisa Meola, Alexander W Tarr, Patrick England, et al.
Hepatology (Baltimore, Md.)|November 22, 2013
Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent mannerNicola F Fletcher, Rupesh Sutaria, Juandy Jo, et al.
Atherosclerosis|March 10, 2024
Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Antisense Oligonucleotide Targeting Hepatic Serum Amyloid A Limits the Progression of Angiotensin II-Induced Abdominal Aortic Aneurysm FormationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Journal of Virological Methods|May 21, 2021
A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirusJessica M van Loben Sels, Luke W Meredith, Stanislav V Sosnovtsev, et al.
The Journal of General Virology|July 22, 2020
A novel antiviral formulation inhibits a range of enveloped virusesNicola F Fletcher, Luke W Meredith, Emma L Tidswell, et al.
Journal of Virology|October 22, 2010
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmissionClaire L Brimacombe, Joe Grove, Luke W Meredith, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Virology|May 22, 2015
Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based RecombinantChristian K Mathiesen, Jannick Prentoe, Luke W Meredith, et al.
Ebiomedicine|January 19, 2020
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patientsJanet T Scott, Raman Sharma, Luke W Meredith, et al.
Influenza and Other Respiratory Viruses|November 15, 2023
Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID-19 and preparedness for other emerging infectious diseases in the Islamic Emirate of AfghanistanMurad Momin Khan, Mohamed Mostafa Tahoun, Luke W Meredith, et al.
Journal of Virology|December 5, 2014
Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodiesAnnalisa Meola, Alexander W Tarr, Patrick England, et al.
Hepatology (Baltimore, Md.)|November 22, 2013
Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent mannerNicola F Fletcher, Rupesh Sutaria, Juandy Jo, et al.
Atherosclerosis|March 10, 2024
Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Antisense Oligonucleotide Targeting Hepatic Serum Amyloid A Limits the Progression of Angiotensin II-Induced Abdominal Aortic Aneurysm FormationPreetha Shridas, Ailing Ji, Andrea C Trumbauer, et al.
Journal of Virological Methods|May 21, 2021
A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirusJessica M van Loben Sels, Luke W Meredith, Stanislav V Sosnovtsev, et al.
The Journal of General Virology|July 22, 2020
A novel antiviral formulation inhibits a range of enveloped virusesNicola F Fletcher, Luke W Meredith, Emma L Tidswell, et al.
Journal of Virology|October 22, 2010
Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmissionClaire L Brimacombe, Joe Grove, Luke W Meredith, et al.
Pageof 4